Shopping Cart
- Remove All
- Your shopping cart is currently empty
Imeglimin (EMD 387008) is an orally available antidiabetic compound that enhances mitochondrial function, enhances insulin secretion, promotes β-cell proliferation and improves pancreatic β-cell survival in mice.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $35 | In Stock | |
5 mg | $79 | In Stock | |
10 mg | $127 | In Stock | |
25 mg | $237 | In Stock | |
50 mg | $383 | In Stock | |
100 mg | $563 | In Stock | |
500 mg | $1,180 | In Stock |
Description | Imeglimin (EMD 387008) is an orally available antidiabetic compound that enhances mitochondrial function, enhances insulin secretion, promotes β-cell proliferation and improves pancreatic β-cell survival in mice. |
In vitro | In Human endothelial cells (HMEC-1), Imeglimin (100 μM and 10 mM; 100 μM for 24 hours, 10 mM for 4 hours) can prevent cell death[2]. |
In vivo | In 4-week-old male C57BL/6JOlaHsd mice, oral administration of Imeglimin (200 mg/kg; b.i.d.; for 6 weeks) caused a slight decrease in body weight and food intake, associated with some diarrhea, but these effects were only observed during the first few days of treatment[1]. |
Alias | RVT-1501, PXL 008, EMD-387008, EMD 387008 |
Molecular Weight | 155.2 |
Formula | C6H13N5 |
Cas No. | 775351-65-0 |
Smiles | Cl.C[C@@H]1N=C(N)NC(=N1)N(C)C |
Relative Density. | 1.29 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.